Landscapes / Targets

complement factor B

4 drugs act on complement factor B, in 18 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs4

DrugHow it worksCompanyStageNext dateDetails
Complement factor B inhibitor
Novartis · Public NVS
Approved 30 Dec 2026Phase 2 trial completes
—
Phase 3 Nov 2026soonPhase 3 trial completes
—
Roche · Public ROG.SW
Phase 3 25 May 2028Phase 3 trial completes
—
Regeneron · Public REGN
Phase 1/2 29 Nov 2029Phase 1/2 trial completes

About this list

Checked
4 of 4 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Complement factor B

Following is part of Solo: you see every change to Complement factor B the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in